Skip to content
10-Q

Quarterly Report

Prime Medicine, Inc. PRME

0001628280-25-050422

← back to feed
Filed
Nov 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 180.51M sh
Shares Diluted Q3 2025 · Sep 30, 2025 160.5M sh
Shares Diluted Q3 2025 · Sep 30, 2025 139.24M sh
Shares Diluted Q3 2025 · Sep 30, 2024 119.76M sh
Shares Diluted Q3 2025 · Sep 30, 2024 114.49M sh
Capex Q3 2025 · Sep 30, 2025 $4.24M
Capex Q3 2025 · Sep 30, 2024 $5.5M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$125.31M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$139.11M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $71.4M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $182.48M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $117.98M
Stockholders Equity Q3 2025 · Sep 30, 2025 $161.82M
Stockholders Equity Q3 2025 · Jun 30, 2025 $60.86M
Stockholders Equity Q3 2025 · Mar 31, 2025 $106.92M
Stockholders Equity Q3 2025 · Dec 31, 2024 $153.15M
Stockholders Equity Q3 2025 · Sep 30, 2024 $189.5M
Stockholders Equity Q3 2025 · Jun 30, 2024 $196.59M
Stockholders Equity Q3 2025 · Mar 31, 2024 $243.77M
Stockholders Equity Q3 2025 · Dec 31, 2023 $133.07M
Current Liabilities Q3 2025 · Sep 30, 2025 $35.02M
Current Liabilities Q3 2025 · Dec 31, 2024 $37.96M
Total Liabilities Q3 2025 · Sep 30, 2025 $223.19M
Total Liabilities Q3 2025 · Dec 31, 2024 $144.36M
Current Assets Q3 2025 · Sep 30, 2025 $231.41M
Current Assets Q3 2025 · Dec 31, 2024 $211.89M
Total Assets Q3 2025 · Sep 30, 2025 $385.01M
Total Assets Q3 2025 · Dec 31, 2024 $297.51M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.32
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.11
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.44
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.34
Eps Basic Q3 2025 · Sep 30, 2025 −$0.32
Eps Basic Q3 2025 · Sep 30, 2025 −$1.11
Eps Basic Q3 2025 · Sep 30, 2024 −$0.44
Eps Basic Q3 2025 · Sep 30, 2024 −$1.34
Sga Expense Q3 2025 · Sep 30, 2025 $11.21M
Sga Expense Q3 2025 · Sep 30, 2025 $37.61M
Sga Expense Q3 2025 · Sep 30, 2024 $14.1M
Sga Expense Q3 2025 · Sep 30, 2024 $37.86M
Rd Expense Q3 2025 · Sep 30, 2025 $43.99M
Rd Expense Q3 2025 · Sep 30, 2025 $125.93M
Rd Expense Q3 2025 · Sep 30, 2024 $40.34M
Rd Expense Q3 2025 · Sep 30, 2024 $121.19M
Net Income Q3 2025 · Sep 30, 2025 −$50.58M
Net Income Q3 2025 · Sep 30, 2025 −$155.06M
Net Income Q3 2025 · Jun 30, 2025 −$52.59M
Net Income Q3 2025 · Mar 31, 2025 −$51.89M
Net Income Q3 2025 · Sep 30, 2024 −$52.52M
Net Income Q3 2025 · Sep 30, 2024 −$153.61M
Net Income Q3 2025 · Jun 30, 2024 −$55.33M
Net Income Q3 2025 · Mar 31, 2024 −$45.76M
Operating Income Q3 2025 · Sep 30, 2025 −$53.97M
Operating Income Q3 2025 · Sep 30, 2025 −$159.74M
Operating Income Q3 2025 · Sep 30, 2024 −$54.23M
Operating Income Q3 2025 · Sep 30, 2024 −$158.25M
Revenue Q3 2025 · Sep 30, 2025 $1.23M
Revenue Q3 2025 · Sep 30, 2025 $3.79M
Revenue Q3 2025 · Sep 30, 2024 $209K
Revenue Q3 2025 · Sep 30, 2024 $800K